D M Sutkowski - JoVE Visualize

Showing results (1-10 of 14) with videos related to

Pageof 2

Sort By:

The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002

Peripheral activity of a new NK1 receptor antagonist TAK-637 in the gastrointestinal tractKalina Venkova, D M Sutkowski-Markmann, B Greenwood-Van Meerveld

Invasion & Metastasis|January 1, 1992

Utilization of the Boyden chamber to further characterize in vitro migration and invasion of benign and malignant human prostatic epithelial cellsC J Fong, D M Sutkowski, J M Kozlowski, et al.

The Journal of Urology|July 1, 1991

Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distributionJ H Kim, E R Sherwood, D M Sutkowski, et al.

The Prostate|February 1, 1996

Stromal cells of the human prostate: initial isolation and characterizationA Kassen, D M Sutkowski, H Ahn, et al.

The Prostate|January 1, 1993

Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude miceD J Lim, X L Liu, D M Sutkowski, et al.

The Prostate|January 1, 1992

Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in cultureD M Sutkowski, C J Fong, J A Sensibar, et al.

The Journal of Urology|May 1, 1993

Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cellsC J Fong, D M Sutkowski, E J Braun, et al.

Cancer Research|June 1, 1995

Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin)J A Sensibar, D M Sutkowski, A Raffo, et al.

The Prostate. Supplement|January 1, 1996

Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5alpha-reductase inhibitorD M Sutkowski, J E Audia, R L Goode, et al.

Endocrinology|February 1, 1995

Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosteroneC Lee, D M Sutkowski, J A Sensibar, et al.

Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:

Pageof 2

The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002

Peripheral activity of a new NK1 receptor antagonist TAK-637 in the gastrointestinal tractKalina Venkova, D M Sutkowski-Markmann, B Greenwood-Van Meerveld

Invasion & Metastasis|January 1, 1992

Utilization of the Boyden chamber to further characterize in vitro migration and invasion of benign and malignant human prostatic epithelial cellsC J Fong, D M Sutkowski, J M Kozlowski, et al.

The Journal of Urology|July 1, 1991

Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distributionJ H Kim, E R Sherwood, D M Sutkowski, et al.

The Prostate|February 1, 1996

Stromal cells of the human prostate: initial isolation and characterizationA Kassen, D M Sutkowski, H Ahn, et al.

The Prostate|January 1, 1993

Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude miceD J Lim, X L Liu, D M Sutkowski, et al.

The Prostate|January 1, 1992

Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in cultureD M Sutkowski, C J Fong, J A Sensibar, et al.

The Journal of Urology|May 1, 1993

Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cellsC J Fong, D M Sutkowski, E J Braun, et al.

Cancer Research|June 1, 1995

Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin)J A Sensibar, D M Sutkowski, A Raffo, et al.

The Prostate. Supplement|January 1, 1996

Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5alpha-reductase inhibitorD M Sutkowski, J E Audia, R L Goode, et al.

Endocrinology|February 1, 1995

Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosteroneC Lee, D M Sutkowski, J A Sensibar, et al.

Pageof 2